ID	Description	GeneRatio	BgRatio	RichFactor	FoldEnrichment	pvalue	p.adjust
GO:0000512	lncRNA-mediated post-transcriptional gene silencing	2/4	11/18805	0.181818181818182	854.772727272727	1.86527618772393e-06	5.50256475378558e-05
GO:2000625	regulation of miRNA catabolic process	2/4	11/18805	0.181818181818182	854.772727272727	1.86527618772393e-06	5.50256475378558e-05
GO:0010587	miRNA catabolic process	2/4	20/18805	0.1	470.125	6.43956855201401e-06	0.000126644848189609
GO:2000630	positive regulation of miRNA metabolic process	2/4	67/18805	0.0298507462686567	140.335820895522	7.46865847444957e-05	0.00110162712498131
GO:2000628	regulation of miRNA metabolic process	2/4	92/18805	0.0217391304347826	102.201086956522	0.000141150138621169	0.0016655716357298
GO:0010586	miRNA metabolic process	2/4	110/18805	0.0181818181818182	85.4772727272727	0.000201890193598079	0.00198525357038111
GO:0040029	epigenetic regulation of gene expression	2/4	308/18805	0.00649350649350649	30.5275974025974	0.00156981328737954	0.013231283422199
GO:0006401	RNA catabolic process	2/4	415/18805	0.00481927710843374	22.6566265060241	0.00283057721316282	0.0167131261841115
GO:0060816	random inactivation of X chromosome	1/4	14/18805	0.0714285714285714	335.803571428571	0.00297484456015817	0.0167131261841115
GO:2000288	positive regulation of myoblast proliferation	1/4	14/18805	0.0714285714285714	335.803571428571	0.00297484456015817	0.0167131261841115
GO:0141188	nucleic acid catabolic process	2/4	444/18805	0.0045045045045045	21.1768018018018	0.00323376298519421	0.0167131261841115
GO:0051290	protein heterotetramerization	1/4	16/18805	0.0625	293.828125	0.00339927990185318	0.0167131261841115
GO:0009048	dosage compensation by inactivation of X chromosome	1/4	21/18805	0.0476190476190476	223.869047619048	0.00445977539045828	0.0202405190797722
GO:0007549	sex-chromosome dosage compensation	1/4	23/18805	0.0434782608695652	204.402173913043	0.00488373651538043	0.0205814610291032
GO:2000291	regulation of myoblast proliferation	1/4	25/18805	0.04	188.05	0.00530756221470419	0.0208764113778365
GO:0031048	regulatory ncRNA-mediated heterochromatin formation	1/4	27/18805	0.037037037037037	174.12037037037	0.00573125251727147	0.0211339936574385
GO:0051291	protein heterooligomerization	1/4	31/18805	0.032258064516129	151.653225806452	0.00657822704749111	0.0228303174001162
GO:0051450	myoblast proliferation	1/4	34/18805	0.0294117647058824	138.272058823529	0.00721310274314058	0.0236429478802941
GO:0002446	neutrophil mediated immunity	1/4	39/18805	0.0256410256410256	120.544871794872	0.00827055261557774	0.0255801932493104
GO:0006418	tRNA aminoacylation for protein translation	1/4	41/18805	0.024390243902439	114.664634146341	0.00869329594817858	0.0255801932493104
GO:0043039	tRNA aminoacylation	1/4	44/18805	0.0227272727272727	106.846590909091	0.00932715751959434	0.0255801932493104
GO:0043038	amino acid activation	1/4	45/18805	0.0222222222222222	104.472222222222	0.00953837714381067	0.0255801932493104
GO:0042119	neutrophil activation	1/4	48/18805	0.0208333333333333	97.9427083333333	0.0101718333681118	0.0260929638573302
GO:0036230	granulocyte activation	1/4	56/18805	0.0178571428571429	83.9508928571428	0.0118595645120741	0.027988572248495
GO:1900087	positive regulation of G1/S transition of mitotic cell cycle	1/4	56/18805	0.0178571428571429	83.9508928571428	0.0118595645120741	0.027988572248495
GO:0140719	constitutive heterochromatin formation	1/4	62/18805	0.0161290322580645	75.8266129032258	0.013123945793263	0.0297812616077892
GO:1902808	positive regulation of cell cycle G1/S phase transition	1/4	71/18805	0.0140845070422535	66.2147887323944	0.0150182421324538	0.0328176402153621
GO:0051262	protein tetramerization	1/4	100/18805	0.01	47.0125	0.0211035394563545	0.0444681724258898
GO:1901992	positive regulation of mitotic cell cycle phase transition	1/4	105/18805	0.00952380952380952	44.7738095238095	0.0221498719630273	0.0450635326144349
GO:0002444	myeloid leukocyte mediated immunity	1/4	116/18805	0.00862068965517241	40.5280172413793	0.0244488507065869	0.0480827397229542
GO:1901989	positive regulation of cell cycle phase transition	1/4	126/18805	0.00793650793650794	37.3115079365079	0.0265353114552218	0.0505026895438093
GO:0045931	positive regulation of mitotic cell cycle	1/4	136/18805	0.00735294117647059	34.5680147058824	0.028618423598391	0.0519104250327809
GO:0030218	erythrocyte differentiation	1/4	138/18805	0.0072463768115942	34.0670289855072	0.0290346445098605	0.0519104250327809
GO:0034101	erythrocyte homeostasis	1/4	149/18805	0.00671140939597315	31.5520134228188	0.0313214691142246	0.054351961109978
GO:0071456	cellular response to hypoxia	1/4	156/18805	0.00641025641025641	30.1362179487179	0.032774616405414	0.0545767989366713
GO:0031507	heterochromatin formation	1/4	160/18805	0.00625	29.3828125	0.0336042518788225	0.0545767989366713
GO:0036294	cellular response to decreased oxygen levels	1/4	163/18805	0.00613496932515337	28.8420245398773	0.0342261281467261	0.0545767989366713
GO:2000045	regulation of G1/S transition of mitotic cell cycle	1/4	176/18805	0.00568181818181818	26.7116477272727	0.036917457782623	0.0565873473491386
GO:0071453	cellular response to oxygen levels	1/4	179/18805	0.00558659217877095	26.2639664804469	0.037537734198123	0.0565873473491386
GO:0002262	myeloid cell homeostasis	1/4	183/18805	0.00546448087431694	25.6898907103825	0.0383643032875516	0.0565873473491386
GO:0006399	tRNA metabolic process	1/4	203/18805	0.00492610837438424	23.1588669950739	0.0424891656340429	0.0591464689059592
GO:1902806	regulation of cell cycle G1/S phase transition	1/4	205/18805	0.0048780487804878	22.9329268292683	0.0429009207657072	0.0591464689059592
GO:0045814	negative regulation of gene expression, epigenetic	1/4	206/18805	0.00485436893203883	22.8216019417476	0.0431067485246821	0.0591464689059592
GO:0000082	G1/S transition of mitotic cell cycle	1/4	240/18805	0.00416666666666667	19.5885416666667	0.0500851617998159	0.0671596487770259
GO:0002274	myeloid leukocyte activation	1/4	251/18805	0.00398406374501992	18.7300796812749	0.0523346900397728	0.0686165936077021
GO:0044843	cell cycle G1/S phase transition	1/4	271/18805	0.003690036900369	17.3477859778598	0.0564145025009272	0.0705939842856472
GO:0090068	positive regulation of cell cycle process	1/4	274/18805	0.00364963503649635	17.1578467153285	0.057025336273402	0.0705939842856472
GO:0051259	protein complex oligomerization	1/4	276/18805	0.0036231884057971	17.0335144927536	0.0574323939951028	0.0705939842856472
GO:0006520	amino acid metabolic process	1/4	283/18805	0.00353356890459364	16.6121908127208	0.0588560582715533	0.0708674987351356
GO:0001666	response to hypoxia	1/4	316/18805	0.00316455696202532	14.8773734177215	0.065545907954936	0.0773441713868245
GO:0036293	response to decreased oxygen levels	1/4	330/18805	0.00303030303030303	14.2462121212121	0.0683732246939162	0.0790984364106089
GO:0048872	homeostasis of number of cells	1/4	339/18805	0.00294985250737463	13.867994100295	0.070187394331404	0.0792538325374289
GO:0045787	positive regulation of cell cycle	1/4	344/18805	0.00290697674418605	13.6664244186047	0.0711941207539616	0.0792538325374289
GO:0070482	response to oxygen levels	1/4	358/18805	0.00279329608938547	13.1319832402235	0.0740086058631079	0.0793910499258794
GO:1901990	regulation of mitotic cell cycle phase transition	1/4	358/18805	0.00279329608938547	13.1319832402235	0.0740086058631079	0.0793910499258794
GO:0030099	myeloid cell differentiation	1/4	455/18805	0.0021978021978022	10.3324175824176	0.0933336721716239	0.0970176506519755
GO:0044772	mitotic cell cycle phase transition	1/4	457/18805	0.00218818380743982	10.2871991247265	0.0937289167315696	0.0970176506519755
GO:1901987	regulation of cell cycle phase transition	1/4	468/18805	0.00213675213675214	10.045405982906	0.0959004524231303	0.0975539084993911
GO:0002443	leukocyte mediated immunity	1/4	483/18805	0.0020703933747412	9.73343685300207	0.0988553455330667	0.0988553455330667